TW002

N/A

Report date: 2023/10/26 16:49:42

Base Information

Drug NameTW002
Drug Alias NameTW-002TW002
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGlial cell line-derived neurotrophic factors stimulants
TargetsGlial cell line-derived neurotrophic factors
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of CaliforniaTreeway BVUniqure
China Registration ClassN/A

Develop Information

Active CompaniesUniqureUniversity Of CaliforniaTreeway BV
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A